Streetbeat News

Stock Prices

ETHUSD

A developer experimenting with their first test token on 4chan mistakenly locked away five Ether (CRYPTO: ETH) for a century, causing the test token's market cap to rise to $6 million before dropping by 70%. The developer had intended to use testing funds on the Ethereum testnet, but instead launched the token on the Ethereum mainnet. The tokens are now inaccessible until December 31, 2123. The incident has been met with skepticism, with some speculating it was a calculated move to attract attention.

Portfolio Pulse from Murtuza Merchant

August 04, 2023 | 2:25 pm

OTEX

Open Text (NASDAQ:OTEX) reported Q4 earnings of $0.91 per share, missing the analyst consensus estimate of $0.94 by 3.19%. The company also reported quarterly sales of $1.49 billion, missing the analyst consensus estimate of $1.51 billion by 1.26%. However, both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 04, 2023 | 2:25 pm

LQDT

Liquidity Services' shares are trading higher after the company reported better than expected earnings for Q3.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:25 pm

LCID

Lucid Group, Inc. (NASDAQ:LCID) shares have been volatile due to the upcoming second-quarter earnings report and the recent downgrade of the US credit rating. The company is expected to report a loss of 35 cents and revenue of $201.94 million. The downgrade has created a negative market sentiment, causing a selloff in the growth sector, including EV stocks like Lucid. However, Lucid's stock benefitted from the strength in the EV market last week.

Portfolio Pulse from Ryan Gustafson

August 04, 2023 | 2:25 pm

ZEUS

Olympic Steel (NASDAQ:ZEUS) reported Q2 earnings of $1.24 per share, beating the analyst consensus estimate of $1.22 by 1.64%. However, this is a 61.96% decrease from the same period last year. The company's quarterly sales were $569.27 million, missing the analyst consensus estimate of $636.41 million by 10.55%, and marking a 19.73% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:24 pm

DRH

Diamondrock Hospitality (NYSE:DRH) reported Q2 earnings of $0.32 per share, a decrease of 11.11% YoY. The company's quarterly sales were $291.20 million, missing the analyst consensus estimate of $295.91 million by 1.59%. However, this is a 3.48% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:24 pm

FSR

Fisker CEO announced on Fox Business that the company expects to produce 300 Fisker Ocean EVs per day later this year.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 2:24 pm

BTCUSD

COIN

ETHUSD

Coinbase Global Inc (NASDAQ:COIN) reported Q2 financial results with total revenue of $707.9 million, beating the Street consensus estimate of $643.36 million. The company reported a loss of 42 cents per share, also beating the Street consensus estimate of a loss of 78 cents per share. Bitcoin represented 40% of trading volume and 39% of transaction revenue in Q2. The company's shares are up 6% to $96 in after-hours trading.

Portfolio Pulse from Chris Katje

August 04, 2023 | 2:24 pm

HUBS

Truist Securities analyst Terry Tillman has reiterated a Buy rating on HubSpot, Inc. (NYSE:HUBS), raising the price target to $600 from $500. This follows HubSpot's Q2 results, which exceeded analyst's estimates in terms of revenue, profitability, EPS, and cash flow. The company's GenAI initiative is receiving positive feedback and traction, and management believes it will be able to implement value-based pricing for certain GenAI features. However, the macro environment remains challenging, with customer buying trends steady and budgets under scrutiny.

Portfolio Pulse from Nabaparna Bhattacharya

August 04, 2023 | 2:24 pm

NARI

Inari Medical Inc's stock gained 21% after reporting Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the consensus of $116.28 million. The company also reported a Q2 EPS of $0.04, a turnaround from an EPS loss of $(0.19), beating the consensus of $(0.14). Inari Medical announced a commitment to a new trial and launched two new products. The company raised the FY23 revenue guidance to $482 million-$492 million.

Portfolio Pulse from Vandana Singh

August 04, 2023 | 2:24 pm